Role of hyperinsulinemia in atherosclerotic coronary arterial disease: Studies of semi-quantitative coronary angiography

Internal Medicine

Volumn 38, Issue 9, 1999, Pages 691-697

  Tsuchihashi, Kazufumi ^a   Hikita, Nobuichi ^a   Hase, Mamoru ^a   Agata, Jun ^a   Saitoh, Shigeyuki ^a   Nakata, Tomoaki ^a   Ura, Nobuyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary arterial disease; Diabetes mellitus; Hyperinsulinemia; Insulin resistance

Indexed keywords

INSULIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOSPITALIZATION; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0033194410     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.691     Document Type: Article

References (35)

1. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 76: 4-12, 1984.
2. Staessen JA, Fagard R, Thijs L, et al. and The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350: 757-764, 1997.
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994.
4. Shepherd J, Cobbe SM, Ford I, et al. and West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307, 1995.
5. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
6. Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514-1520, 1989.
7. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
8. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54-59, 1987.
9. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in nonobese men. Atherosclerosis 107: 239-246, 1994.
10. Nakagawa M, Shimamoto K, Masuda A, et al. The effects of body fat composition and family history of hypertension on insulin resistance. J Hypertens 10 (Suppl 4): S88, 1992.
11. Tanaka S, Takagi Y, Kondoh S, et al. Epidemiological studies on impaired Glucose tolerance and the progression of hypertension. Hypertens Res 14: 37, 1991 (Japanese).
12. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 34: 356-361, 1991.
13. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
14. Ley CJ, Swan J, Godsland IF, et al. Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram. J Am Coll Cardiol 23: 377-383, 1994.
15. Howard G, O'Leary DH, Zaccaro D, et al. and The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817, 1996.
16. Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography, Diabetes Care 19: 1-7, 1996.
17. Bavenholm P, Proudler A, Tornvall P, et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92: 1422-1429, 1995.
18. Shen SW, Reaven GM, Farquhar JW: Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49: 2151-2160, 1970.
19. Iimura O. Insulin resistance and hypertension in Japanese. Hypertens Res 19 (Suppl 1): S1-S8, 1996.
20. Agata J, Shimamoto K, Masuda A. Pathphysiological significance of insulin sensitivity on essential hypertension. Sapporo Med J 65: 511-520, 1996 (Japanese in English abstract).
21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
22. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 14 (Suppl 4): 39-47, 1991.
23. Harano Y, Kageyama A, Hirose J, et al. Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects. Metabolism 44: 315-319, 1995.
24. Orchard TJ, Eichner J, Kuller LH, et al. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol 4: 40-45, 1994.
25. Yarnell JW, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J 71: 293-296, 1994.
26. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 91: 831-837, 1995.
27. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 140: 857-869, 1994.
28. Dortimer AC, Shenoy PN, Shiroff RA, et al. Diffuse coronary artery disease in diabetic patients. Fact or fiction? Circulation 57: 133-136, 1978.
29. Lemp GF, Vander Zwaag R, Hughes JP, et al. Association between the severity of diabetes mellitus and coronary arterial atherosclerosis. Am J Cardiol 60: 1015-1019, 1987.
30. DeStefano F, Ford ES, Newman J, et al. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 3: 27-34, 1993.
31. Kip KE, Faxon DP, Detre KM, et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94: 1818-1825, 1996.
32. Takeda Y, Mifune J, Taga K, et al. Multiple risk factors in coronary artery disease patients with abnormal glucose tolerance. Jpn Heart J 32: 35-43, 1991.
33. Vigorita VJ, Moore GW, Hutchins GM. Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol 46: 535-542, 1980.
34. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 69: 498-506, 1980.
35. Hikita N, Tsuchihashi K, Nakata T, Ura N, Shimamoto K. Role of glucose metabolic abnormalties and the insulin resistance influenced on atherosclerotic coronary artery disease: studies of semi quantitative coronary angiography. J Cardiol 24: 1291-1300, 1998 (in Japanese with English Abstract).